SanFran and others.

I'm willing to bet there are a significant number of investors holding large blocks of Zenith shares and who are extremely upset with Don's performance regarding lack of liquidity or a NASDAQ listing, management failure with the Cherrington fiasco, the patent issue with the previous lead drug and other issues that he does not want to face them in a public update allowing for questions.

My bet is that he is attempting to buy enough time on the zen3694 trial to be able to say something hopeful about the prospects.

I think he is trying to lay low and stay unavailable for the time being.

As always I hope to be proven wrong. If there are early signs of a hit with zen3694 I believe the impact will be very significant and may even lead apabetalone in terms of timing, BP interest, etc.

GLTA

Toinv